Reaping the benefits of genomic and proteomic research: intellectual property rights, innovation, and public health
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
©2006
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | "Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy, Committee on Science, Technology, and Law, Policy and Global Affairs, National Research Council of the National Academies." Includes bibliographical references Genomics, proteomics, and the changing research environment -- The U.S. patent system, biotechnology, and the courts -- Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research -- Conclusions and recommendations The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results |
| Beschreibung: | 1 Online-Ressource (xvi, 171 pages) |
| ISBN: | 0309100674 0309655234 9780309100670 9780309655231 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043092608 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2006 |||| o||u| ||||||eng d | ||
| 020 | |a 0309100674 |9 0-309-10067-4 | ||
| 020 | |a 0309655234 |9 0-309-65523-4 | ||
| 020 | |a 9780309100670 |9 978-0-309-10067-0 | ||
| 020 | |a 9780309655231 |9 978-0-309-65523-1 | ||
| 035 | |a (OCoLC)66295941 | ||
| 035 | |a (DE-599)BVBBV043092608 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 572.8/6 |2 22 | |
| 245 | 1 | 0 | |a Reaping the benefits of genomic and proteomic research |b intellectual property rights, innovation, and public health |c Stephen A. Merrill and Anne-Marie Mazza, editors |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c ©2006 | |
| 300 | |a 1 Online-Ressource (xvi, 171 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a "Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy, Committee on Science, Technology, and Law, Policy and Global Affairs, National Research Council of the National Academies." | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Genomics, proteomics, and the changing research environment -- The U.S. patent system, biotechnology, and the courts -- Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research -- Conclusions and recommendations | ||
| 500 | |a The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results | ||
| 650 | 4 | |a Genomics | |
| 650 | 4 | |a Proteomics | |
| 650 | 4 | |a Intellectual Property | |
| 650 | 4 | |a Patents | |
| 650 | 4 | |a Public Health | |
| 650 | 7 | |a SCIENCE / Life Sciences / Genetics & Genomics |2 bisacsh | |
| 650 | 7 | |a Genomics |2 fast | |
| 650 | 7 | |a Intellectual property |2 fast | |
| 650 | 7 | |a Proteomics |2 fast | |
| 650 | 4 | |a Genomics |z United States |x Patents | |
| 650 | 4 | |a Proteomics |z United States |x Patents | |
| 650 | 4 | |a Intellectual property |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Merrill, Stephen A. |e Sonstige |4 oth | |
| 700 | 1 | |a Mazza, Anne-Marie |e Sonstige |4 oth | |
| 710 | 2 | |a National Research Council (U.S.) |b Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028516800 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175494938099712 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043092608 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)66295941 (DE-599)BVBBV043092608 |
| dewey-full | 572.8/6 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 572 - Biochemistry |
| dewey-raw | 572.8/6 |
| dewey-search | 572.8/6 |
| dewey-sort | 3572.8 16 |
| dewey-tens | 570 - Biology |
| discipline | Biologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04195nmm a2200577zc 4500</leader><controlfield tag="001">BV043092608</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2006 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309100674</subfield><subfield code="9">0-309-10067-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309655234</subfield><subfield code="9">0-309-65523-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309100670</subfield><subfield code="9">978-0-309-10067-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309655231</subfield><subfield code="9">978-0-309-65523-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)66295941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043092608</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">572.8/6</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Reaping the benefits of genomic and proteomic research</subfield><subfield code="b">intellectual property rights, innovation, and public health</subfield><subfield code="c">Stephen A. Merrill and Anne-Marie Mazza, editors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">©2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvi, 171 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy, Committee on Science, Technology, and Law, Policy and Global Affairs, National Research Council of the National Academies."</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Genomics, proteomics, and the changing research environment -- The U.S. patent system, biotechnology, and the courts -- Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research -- Conclusions and recommendations</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteomics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intellectual Property</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCIENCE / Life Sciences / Genetics & Genomics</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genomics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intellectual property</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Proteomics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield><subfield code="z">United States</subfield><subfield code="x">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Proteomics</subfield><subfield code="z">United States</subfield><subfield code="x">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intellectual property</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Merrill, Stephen A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mazza, Anne-Marie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Research Council (U.S.)</subfield><subfield code="b">Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028516800</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043092608 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:11Z |
| institution | BVB |
| isbn | 0309100674 0309655234 9780309100670 9780309655231 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028516800 |
| oclc_num | 66295941 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xvi, 171 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health Stephen A. Merrill and Anne-Marie Mazza, editors Washington, D.C. National Academies Press ©2006 1 Online-Ressource (xvi, 171 pages) txt rdacontent c rdamedia cr rdacarrier "Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy, Committee on Science, Technology, and Law, Policy and Global Affairs, National Research Council of the National Academies." Includes bibliographical references Genomics, proteomics, and the changing research environment -- The U.S. patent system, biotechnology, and the courts -- Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research -- Conclusions and recommendations The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results Genomics Proteomics Intellectual Property Patents Public Health SCIENCE / Life Sciences / Genetics & Genomics bisacsh Genomics fast Intellectual property fast Proteomics fast Genomics United States Patents Proteomics United States Patents Intellectual property United States USA Merrill, Stephen A. Sonstige oth Mazza, Anne-Marie Sonstige oth National Research Council (U.S.) Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238 Aggregator Volltext |
| spellingShingle | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health Genomics Proteomics Intellectual Property Patents Public Health SCIENCE / Life Sciences / Genetics & Genomics bisacsh Genomics fast Intellectual property fast Proteomics fast Genomics United States Patents Proteomics United States Patents Intellectual property United States |
| title | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health |
| title_auth | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health |
| title_exact_search | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health |
| title_full | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health Stephen A. Merrill and Anne-Marie Mazza, editors |
| title_fullStr | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health Stephen A. Merrill and Anne-Marie Mazza, editors |
| title_full_unstemmed | Reaping the benefits of genomic and proteomic research intellectual property rights, innovation, and public health Stephen A. Merrill and Anne-Marie Mazza, editors |
| title_short | Reaping the benefits of genomic and proteomic research |
| title_sort | reaping the benefits of genomic and proteomic research intellectual property rights innovation and public health |
| title_sub | intellectual property rights, innovation, and public health |
| topic | Genomics Proteomics Intellectual Property Patents Public Health SCIENCE / Life Sciences / Genetics & Genomics bisacsh Genomics fast Intellectual property fast Proteomics fast Genomics United States Patents Proteomics United States Patents Intellectual property United States |
| topic_facet | Genomics Proteomics Intellectual Property Patents Public Health SCIENCE / Life Sciences / Genetics & Genomics Intellectual property Genomics United States Patents Proteomics United States Patents Intellectual property United States USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=156238 |
| work_keys_str_mv | AT merrillstephena reapingthebenefitsofgenomicandproteomicresearchintellectualpropertyrightsinnovationandpublichealth AT mazzaannemarie reapingthebenefitsofgenomicandproteomicresearchintellectualpropertyrightsinnovationandpublichealth AT nationalresearchcounciluscommitteeonintellectualpropertyrightsingenomicandproteinresearchandinnovation reapingthebenefitsofgenomicandproteomicresearchintellectualpropertyrightsinnovationandpublichealth |